Nobivac®

Feline 1-HCP

A quality core vaccine shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses.

FELINE 1-HCP VACCINE PROVIDES TRIPLE VIRUS PROTECTION

Feline Rhinotracheitis Virus, Feline Calicivirus, Feline Panleukopenia Virus (modified live viruses).

  • A quality core vaccine shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses.
  • Effective against the most common threatening viral infections—calicivirus, herpesvirus, and the deadly feline parvovirus, panleukopenia
  • Nobivac® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats1
    • Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia62-63
  • Non-adjuvanted formula
  • Optimal choice for healthy indoor cats

INDICATIONS:

Shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses.

ADMINISTRATION AND DOSAGE

  • Subcutaneous or intramuscular injection
  • Initial 1 mL dose administered at 9 weeks of age or older
  • Second 1 mL dose administered 3 to 4 weeks later
  • Annual revaccination with 1 dose is recommended
  • Available in a 25 x 1 mL dose presentation

Professional Resources and Educational Materials

Keep your clinic and staff informed and aware of diseases and outbreaks.

Feline Leukemia Virus

Brochure

Educate your clients about FeLV with this easy to share brochure.

Download

Feline Sarcomas – What Do We Really Know

Guide

Feline Sarcomas – What Do We Really Know

Download

Feline Vaccination Guide

Brochure

A guide to help your pet parents understand common canine diseases and the importance of customizing vaccination for their pet’s unique lifestyle.

Download

No items to show.

Loading…

References:

1. Data on file, Merck Animal Health.

62. Ikeda Y, Nakamura K, Miyazawa T, Takahashi E, Mochizuki M. Feline host range of canine parvovirus: recent emergence of new antigenic types in cats. Emerg Infect Dis. 2002;8(4):341–346. 

63. Truyen U. Emergence and recent evolution of canine parvovirus. Vet Microbiol. 1999;69(1–2):47–50.

View All Nobivac References